Related references
Note: Only part of the references are listed.Expression of HER2 and estrogen receptor α depends upon nuclear localization of Y-box binding protein-1 in human breast cancers
Teruhiko Fujii et al.
CANCER RESEARCH (2008)
Twist promotes tumor cell growth through YB-1 expression
Masaki Shiota et al.
CANCER RESEARCH (2008)
Different expression profiles of Y-box-binding protein-1 and multidrug resistance-associated proteins between alveolar and embryonal rhabdomyosarcoma
Yoshinao Oda et al.
CANCER SCIENCE (2008)
The extracellular matrix protein ITIH5 is a novel prognostic marker in invasive node-negative breast cancer and its aberrant expression is caused by promoter hypermethylation
J. Veeck et al.
ONCOGENE (2008)
Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells
Anna L. Stratford et al.
BREAST CANCER RESEARCH (2008)
Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes
Golareh Habibi et al.
BREAST CANCER RESEARCH (2008)
Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression
Hui-Wen Lo et al.
CANCER RESEARCH (2007)
Stimulation of NEIL2-mediated oxidized base excision repair via YB-1 interaction during oxidative stress
Soumita Das et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The phosphoinositide-dependent kinase-1 inhibitor 2-AminoN-[ 4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1yl] phenyl]-acetamide (OSU-03012) prevents y-box binding protein-1 from inducing epidermal growth factor receptor
K. To et al.
MOLECULAR PHARMACOLOGY (2007)
Prognostic implications of the nuclear localization of Y-box-binding protein-1 and CXCR4 expression in ovarian cancer: Their correlation with activated Akt, LRP/MVP and P-glycoprotein expression
Yoshinao Oda et al.
CANCER SCIENCE (2007)
The increased expression of Y box-binding protein 1 in melanoma stimulates proliferation and tumor invasion, antagonizes apoptosis and enhances chemoresistance
Birgit Schittek et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Akt-dependent nuclear localization of Y-box-binding protein 1 in acquisition of malignant characteristics by human ovarian cancer cells
Y. Basaki et al.
ONCOGENE (2007)
Epidermal growth factor receptor (EGFR) is transcriptionally induced by the Y-box binding protein-1 (YB-1) and can be inhibited with Iressa in basal-like breast cancer, providing a potential target for therapy
Anna L. Stratford et al.
BREAST CANCER RESEARCH (2007)
Cold shock domain family members YB-1 and MSY4 share essential functions during murine embryogenesis
Zhi Hong Lu et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Molecular profiling of laser-microdissected matched tumor and normal breast tissue identifies karyopherin α2 as a potential novel prognostic marker in breast cancer
Edgar Dahl et al.
CLINICAL CANCER RESEARCH (2006)
Disruption of the Y-box binding protein-1 results in suppression of the epidermal growth factor receptor and HER-2
Joyce Wu et al.
CANCER RESEARCH (2006)
Y-box binding protein 1 - Providing a new angle on translational regulation
Valentina Evdokimova et al.
CELL CYCLE (2006)
Akt-mediated YB-1 phosphorylation activates translation of silent mRNA species
V Evdokimova et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Increased nuclear localization of transcription factor Y-box binding protein 1 accompanied by up-regulation of P-glycoprotein in breast cancer pretreated with paclitaxel
T Fujita et al.
CLINICAL CANCER RESEARCH (2005)
Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy
XJ Cui et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Proteasome-mediated cleavage of the Y-box-binding protein 1 is linked to DNA-damage stress response
AV Sorokin et al.
EMBO JOURNAL (2005)
Y-box protein 1 mediates PDGF-B effects in mesangioproliferative glomerular disease
CRC van Roeyen et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cells
BW Sutherland et al.
ONCOGENE (2005)
YB-1 provokes breast cancer through the induction of chromosomal instability that emerges from mitotic failure and centrosome amplification
S Bergmann et al.
CANCER RESEARCH (2005)
Y-box-binding protein 1 confers EGF independence to human mammary epithelial cells
IM Berquin et al.
ONCOGENE (2005)
Transcription factor YB-1 mediates DNA polymerase α gene expression
A En-Nia et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Co-expression of Y box-binding protein-1 and P-glycoprotein as a prognostic marker for survival in epithelial ovarian cancer
X Huang et al.
GYNECOLOGIC ONCOLOGY (2004)
Nuclear YB-1 expression as a negative prognostic marker in nonsmall cell lung cancer
C Gessner et al.
EUROPEAN RESPIRATORY JOURNAL (2004)
YB-11s upregulated during prostate cancer tumor progression and increases P-glycoprotein activity
P Giménez-Bonafé et al.
PROSTATE (2004)
Transcriptomic changes in human breast cancer progression as determined by serial analysis of gene expression
MC Abba et al.
BREAST CANCER RESEARCH (2004)
YB-1 as a cell cycle-regulated transcription factor facilitating cyclin A and cyclin B1 gene expression
K Jürchott et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The pleiotropic functions of the Y-box-binding protein, YB-1
K Kohno et al.
BIOESSAYS (2003)
Splicing factor SRp30c interaction with Y-box protein-1 confers nuclear YB-1 shuttling and alternative splice site selection
U Raffetseder et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Nuclear expression of YB-1 protein correlates with P-glycoprotein expression in human breast carcinoma
H Saji et al.
CANCER LETTERS (2003)
Nuclear expression of Y-box-binding protein-1 correlates with P-glycoprotein and topoisomerase II alpha expression, and with poor prognosis in synovial sarcoma
Y Oda et al.
JOURNAL OF PATHOLOGY (2003)
The basic and clinical implications of ABC transporters, Y-box-binding protein-1 (YB-1) and angiogenesis-related factors in human malignancies
M Kuwano et al.
CANCER SCIENCE (2003)
Increased nuclear localization of transcription factor YB-1 in acquired cisplatin-resistant ovarian cancer
H Yahata et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2002)
Y-box factor YB-1 predicts drug resistance and patient outcome in breast cancer independent of clinically relevant tumor biologic factors HER2, uPA and PAI-1
M Janz et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
The major mRNA-associated protein YBA is a potent 5′ cap-dependent mRNA stabilizer
V Evdokimova et al.
EMBO JOURNAL (2001)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Expression of survivin, YB-1, and KI-67 in sporadic adenomas and dysplasia-associated lesions or masses in ulcerative colitis
F Fogt et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2001)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
Thrombin activates a Y box-binding protein (DNA-binding protein B) in endothelial
OI Stenina et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Share Paper
